Work

Iatrogenic Cushing’s Syndrome from a Joint Health Supplement: Identification of Undeclared Pharmaceuticals by High-Resolution Mass Spectrometry

Year: 2026

Type: article

Abstract: ACTH: adrenocorticotropic hormone BMI: body mass index HPA: hypothalamic-pituitary-adrenal LC-HRMS: liquid chromatography-high-resolution quadrupole time-of-flight mass spectrometry LC-MS/MS: liquid chromatography-tandem mass spectrometry NSAID: nonsteroidal anti-inflammatory drug abbreviations ChatGPT (OpenAI) was used to assist with language refinement, paraphrasing, and improving clarity of the manuscript text.No artificial intelligence tools were used for data analysis, interpretation, or generation of results.artifiCial intelligenCe useThe authors declare that the research was conducted in the absence of any financial, commercial, or other relationships that could be construed as a potential competing interest.This case report was conducted in accordance with institutional guidelines.Institutional review board approval was not required for publication of a single-patient case report.Written informed consent for publication was not obtained because it was not required under institutional policy for this de-identified single-patient case report.

Source: Journal of Mass Spectrometry and Advances in the Clinical Lab

DOI: 10.21627/2xkas668

Authors: Hannah Lusk, Kara Lynch, Sarah Kim

Institution: University of California, San Francisco

Language: English

Topic: Pharmaceutical Quality and Counterfeiting

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $900